This study focuses on pelvic exenteration as a solution for chronic fistulating pelvic sepsis, a rare complication stemming from pelvic cancer treatment. The research includes 19 patients who underwent radical resection after previous pelvic cancer treatments. Promisingly, the procedure proved safe and effective, with no intraoperative or postoperative deaths. While some patients faced major complications […]
Author: STITCHES Newsletter
Effectiveness of High Ligation of Inferior Mesenteric Artery in Left-Sided Colon and Rectal Cancer Surgery
This study assessed the success rates and outcomes of high ligation of the inferior mesenteric artery (IMA) in left-sided colon and rectal cancer surgery. Results showed that high ligation was technically successful in the majority of cases, with 61.5% of operative reports indicating high ligation. However, there was no significant difference in patient outcomes between […]
Successful Laparoscopic Management of Iatrogenic Colon Perforation: A Promising Approach
Iatrogenic colon perforation, a rare but serious complication of colonoscopy, was studied to determine effective treatment approaches. Out of 51 cases, 84% required surgery. Notably, laparoscopic surgery was performed in 88% of cases, demonstrating its safety and feasibility. Laparoscopic primary suturing was successful in 80% of cases, with a high recovery rate of 96%. The […]
Timely Closure of Ileostomies: A Regional Australian Hospital’s Experience
This study explores the timing and reasons for delaying loop ileostomy closure in regional Australian hospitals. Of the 123 patients who received loop ileostomies between 2010 and 2020, 86.2% had their stomas reversed. Patients with rectal cancer experienced a median time to closure of 8.5 months, while non-rectal cancer patients had a median closure time […]
How Compensation Models Influence Academic Surgeons
This qualitative study delves into the world of academic surgeons, exploring how compensation structures, whether based on clinical productivity incentives or fixed salaries, impact their experiences. While incentivizing high-quality patient care, education, and innovation is the ideal aim, the interplay between compensation models and clinical activities, practice development, and surgeon well-being has remained uncharted territory. […]
Thoraco-Abdominal Chemo and Surgery for Peritoneal Carcinomatosis: Is It Safe and Effective?
This study delves into the safety and effectiveness of combining hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) with cytoreductive surgery (CRS) in patients with peritoneal carcinomatosis (PC) who need diaphragm resection. Researchers compared HITAC to traditional intraperitoneal chemotherapy (HIPEC). Results show that HITAC is a viable option with similar safety profiles, and it might offer benefits for […]
The Great Gastric Cancer Debate: Is Neoadjuvant Radiation Worth Adding to Chemo?
This study navigates the ongoing debate over whether neoadjuvant radiation should be combined with chemotherapy in the treatment of resectable gastric cancer. While awaiting results from specific clinical trials, experts discuss the pros and cons. Neoadjuvant radiation may be better tolerated and improve pathologic response, especially for certain tumor locations. However, it hasn’t shown a […]
Diverse Asian American Groups Show Varying Pancreatic Cancer Survival Rates
This study delves into pancreatic cancer outcomes in the disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) population, which is often underrepresented in scientific research. Analyzing data from 296,448 patients, it reveals that AANHPI patients, as a whole, exhibited better median survival than Caucasians and African Americans. Notably, survival rates varied among AANHPI subpopulations, […]
Mesenteric Lymph Nodes Not Linked to Ovarian Cancer Survival
Researchers examined the role of mesenteric lymph nodes (MLNs) in digestive resection for advanced ovarian cancer (OC) with peritoneal metastases. Out of 159 patients, 77 underwent digestive resection, with 61.1% having MLNs examined, and 56.8% showed involvement. Surprisingly, MLN status didn’t significantly impact overall survival or progression-free survival. This calls for further systematic and standardized […]
Repeat Cytoreduction and HIPEC Boost Survival in Recurrent Appendiceal Adenocarcinoma
When dealing with recurring mucinous appendiceal adenocarcinoma, undergoing repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can be a game-changer. This study from MD Anderson Cancer Center reveals that patients who opt for repeat CRS/HIPEC enjoy similar recurrence-free survival compared to those initially treated, and even better overall survival than patients relying solely on […]